Needham & Company LLC Has Lowered Expectations for Cooper Companies (NASDAQ:COO) Stock Price

Cooper Companies (NASDAQ:COO) had its target price cut by equities research analysts at Needham & Company LLC from $101.00 to $86.00 in a research note issued to investors on Friday, MarketBeat.com reports. The firm presently has a “buy” rating on the medical device company’s stock. Needham & Company LLC’s target price would indicate a potential upside of 38.66% from the company’s previous close.

Other analysts have also issued reports about the stock. Citigroup restated a “neutral” rating and set a $69.00 price objective (down from $80.00) on shares of Cooper Companies in a research note on Thursday, May 28th. Piper Sandler set a $86.00 price objective on shares of Cooper Companies and gave the stock an “overweight” rating in a report on Monday. Mizuho set a $85.00 price objective on Cooper Companies and gave the company an “outperform” rating in a research report on Thursday. Wells Fargo & Company reiterated a “sell” rating and set a $66.00 target price on shares of Cooper Companies in a research note on Friday. Finally, Barclays lifted their target price on Cooper Companies from $98.00 to $103.00 and gave the stock an “overweight” rating in a report on Friday, March 6th. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, six have given a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat.com, Cooper Companies has a consensus rating of “Hold” and an average price target of $84.79.

Cooper Companies Price Performance

Shares of NASDAQ COO opened at $62.02 on Friday. Cooper Companies has a fifty-two week low of $58.89 and a fifty-two week high of $89.83. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.79 and a current ratio of 1.34. The company has a market capitalization of $12.10 billion, a price-to-earnings ratio of 30.70, a P/E/G ratio of 1.56 and a beta of 0.87. The company has a 50 day simple moving average of $65.17 and a two-hundred day simple moving average of $74.57.

Cooper Companies (NASDAQ:COO) last released its earnings results on Thursday, June 4th. The medical device company reported $1.21 EPS for the quarter, topping the consensus estimate of $1.10 by $0.11. Cooper Companies had a return on equity of 10.34% and a net margin of 9.67%.The business had revenue of $1.08 billion for the quarter, compared to the consensus estimate of $1.05 billion. During the same period in the previous year, the company posted $0.96 earnings per share. The company’s revenue for the quarter was up 7.9% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Analysts expect that Cooper Companies will post 4.62 EPS for the current fiscal year.

Institutional Investors Weigh In On Cooper Companies

Hedge funds have recently added to or reduced their stakes in the stock. Capital World Investors boosted its stake in shares of Cooper Companies by 25.7% in the 3rd quarter. Capital World Investors now owns 10,551,592 shares of the medical device company’s stock worth $723,417,000 after buying an additional 2,159,233 shares during the last quarter. State Street Corp increased its position in Cooper Companies by 2.4% during the fourth quarter. State Street Corp now owns 8,793,747 shares of the medical device company’s stock valued at $720,736,000 after acquiring an additional 207,195 shares during the last quarter. Wellington Management Group LLP lifted its holdings in Cooper Companies by 332.9% in the third quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company’s stock valued at $424,043,000 after acquiring an additional 4,756,178 shares during the period. Price T Rowe Associates Inc. MD boosted its position in Cooper Companies by 58.8% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 6,028,821 shares of the medical device company’s stock worth $494,123,000 after purchasing an additional 2,231,568 shares during the last quarter. Finally, Sustainable Growth Advisers LP boosted its position in Cooper Companies by 22.1% in the third quarter. Sustainable Growth Advisers LP now owns 4,132,535 shares of the medical device company’s stock worth $283,327,000 after purchasing an additional 747,476 shares during the last quarter. 24.39% of the stock is currently owned by hedge funds and other institutional investors.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.